MTOR and Alzheimer disease: Several pathways, such as phosphatidylinositol-3-kinase–protein kinase B (PI3K/PKB), mitogen-activated protein kinases (MAPKs), and the mammalian target of rapamycin (mTOR) signaling, are modulated during apoptosis in AD (Sharma et al., 2021).